FIELD: medicine. SUBSTANCE: method involves selecting recombinant yeast vaccine against hepatitis B best of all in the amount of 1 ml once a month during 3 months. Sodium nucleinate is additionally usable. EFFECT: accelerated treatment course. 2 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTIVIRAL PREPARATION AND METHOD OF PREPARING IMMUNOGLOBULIN FOR PROPHYLAXIS AND TREATMENT OF PATIENT WITH VIRAL DISEASES | 1999 |
|
RU2144379C1 |
METHOD OF VACCINATION AGAINST VIRAL HEPATITIS B | 1997 |
|
RU2116086C1 |
PHARMACEUTICAL COMPOSITION FOR VIRAL HEPATITIS B PROPHYLAXIS | 1998 |
|
RU2135209C1 |
METHOD OF TREATMENT OF ACUTE VIRAL HEPATITIS B | 2001 |
|
RU2207135C2 |
MIXED VACCINE FOR IMMUNE PROPHYLAXIS OF VIRAL HEPATITIS B, TETANUS, DIPHTHERIA AND WHOOPING COUGH | 1998 |
|
RU2130778C1 |
METHOD FOR DIAGNOSING MYASTHENIA | 1994 |
|
RU2098106C1 |
METHOD FOR PREDICTION OF ANTIVIRAL THERAPY (AVT) EFFICACY IN CHRONIC HEPATITIS B (CHB) | 2011 |
|
RU2454666C1 |
METHOD FOR PREDICTING EFFICIENCY OF INTERFERONOTHERAPY AT CHRONIC HEPATITIS B | 2005 |
|
RU2287826C1 |
METHOD FOR PREDICTING HEPATITIS SYNDROME IN PATIENTS WITH CHRONIC RENAL FAILURE AT CHRONIC HEMODIALYSIS | 2003 |
|
RU2238568C1 |
METHOD FOR DIAGNOSTICS OF CHRONIC HEPATITIS IN ALCOHOLISM-SUFFERING HBAg CARRIERS | 2001 |
|
RU2201764C1 |
Authors
Dates
2001-05-20—Published
1999-06-30—Filed